Work

Targeted drug development in melanoma and nonsmall cell lung cancer: BRAF, MEK, and ALK inhibitors

Year: 2012

Type: article

Source: memo - Magazine of European Medical Oncology

DOI: 10.1007/s12254-012-0058-4

Authors: Ming Chi, Igor Puzanov

Institutions: University of Illinois Chicago, Saint Joseph Hospital, Vanderbilt University Medical Center

Language: English

Topic: Melanoma and MAPK Pathways

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2071208249

FWCI:

Cites: 63

Cited by:

Related to: 10